EMN Financials Eastman Chemical Co

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Nov 1, 2026, 10:31 UTC Overview →

Growth & profitability

Revenue has grown 0.7% per year over the past 5 years.
Net income has grown slower than revenue (-0.2% vs 0.7% per year).
Free cash flow has declined 16.9% per year over the past 5 years.

Financial health

Total debt ($4.8B) exceeds cash ($566M); net debt is $4.2B.
Total debt has grown slower than revenue (-3.2% vs 0.7% per year).

Shareholder returns

Dividends have been paid for 15 consecutive years, consuming 80.4% of earnings and 89.9% of free cash flow.
The dividend has grown 1.3% per year over the past 5 years.

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key annual figures

FY	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
2025	$8.8B	$474M	21.1%	0.0%	8.0%	3.2%	$424M	$4.8B	$566M
2024	$9.4B	$905M	24.4%	0.0%	15.7%	5.9%	$688M	$5.0B	$837M
2023	$9.2B	$894M	22.4%	0.0%	16.4%	6.1%	$546M	$4.8B	$548M
2022	$10.6B	$793M	20.2%	0.0%	15.4%	5.4%	$364M	$5.2B	$493M
2021	$10.5B	$857M	23.9%	0.0%	15.0%	5.5%	$1.1B	$5.2B	$459M
2020	$8.5B	$478M	23.3%	0.0%	7.9%	3.0%	$1.1B	$5.6B	$564M
2019	$9.3B	$759M	24.1%	0.0%	12.7%	4.7%	$1.1B	$5.8B	$204M
2018	$10.2B	$1.1B	24.4%	0.0%	18.6%	6.8%	$1.0B	$6.2B	—
2017	$9.5B	$1.4B	24.7%	16.0%	25.6%	8.7%	$1.0B	$6.5B	—
2016	$9.0B	$854M	26.2%	15.4%	18.8%	5.5%	$759M	$6.6B	—
2015	$9.6B	$848M	26.7%	14.3%	21.5%	5.4%	$972M	$7.0B	—
2014	$9.5B	$751M	23.3%	12.2%	21.4%	4.7%	$840M	$7.5B	—
2013	$9.3B	$1.2B	29.7%	19.9%	30.7%	9.8%	$814M	$4.3B	—
2012	$8.1B	$437M	21.7%	9.9%	14.8%	3.7%	$663M	$4.8B	—
2011	$7.2B	$646M	21.9%	13.1%	34.5%	10.4%	$168M	$1.8B	—

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex, quarterly)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key quarterly figures

Quarter	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
Sep '26	$2.4B	$252M	22.3%	0.0%	4.0%	1.6%	$195M	$5.2B	$768M
Jun '26	$2.5B	$183M	22.3%	0.0%	3.0%	1.2%	$124M	$5.2B	$691M
Mar '26	$2.2B	$107M	19.8%	0.0%	1.8%	0.7%	-$240M	$5.2B	$665M
Dec '25	$2.0B	$105M	17.1%	0.0%	1.8%	0.7%	$390M	$4.8B	$566M
Sep '25	$2.2B	$69M	19.7%	0.0%	1.2%	0.5%	$265M	$5.1B	$489M
Jun '25	$2.3B	$140M	22.1%	0.0%	2.4%	0.9%	$83M	$5.1B	$423M
Mar '25	$2.3B	$182M	24.8%	0.0%	3.1%	1.2%	-$314M	$5.0B	$418M
Dec '24	$2.2B	$330M	24.7%	0.0%	5.7%	2.2%	$361M	$5.0B	$837M
Sep '24	$2.5B	$180M	24.6%	0.0%	3.2%	1.2%	$276M	$5.1B	$622M
Jun '24	$2.4B	$230M	25.3%	0.0%	4.1%	1.5%	$252M	$5.0B	$514M
Mar '24	$2.3B	$165M	23.0%	0.0%	3.0%	1.1%	-$201M	$5.1B	$499M
Dec '23	$2.2B	$310M	21.0%	0.0%	5.7%	2.1%	$273M	$4.8B	$548M
Sep '23	$2.3B	$178M	21.3%	0.0%	3.3%	1.2%	$278M	$5.2B	$439M
Jun '23	$2.3B	$272M	25.1%	0.0%	5.2%	1.8%	$171M	$5.4B	$410M
Mar '23	$2.4B	$134M	21.9%	0.0%	2.6%	0.9%	-$176M	$5.7B	$599M
Dec '22	$2.4B	$1M	15.8%	0.0%	0.0%	0.0%	$254M	$5.2B	$493M
Sep '22	$2.7B	$301M	20.0%	0.0%	5.6%	2.0%	$95M	$5.1B	$461M
Jun '22	$2.8B	$256M	24.1%	0.0%	4.8%	1.7%	$110M	$5.0B	$456M
Mar '22	$2.7B	$235M	20.3%	0.0%	4.0%	1.5%	-$95M	$5.4B	$487M
Dec '21	$2.7B	$378M	20.7%	0.0%	6.6%	2.4%	$190M	$5.2B	$459M

Valuation over time

How the market has priced EMN against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

The price-to-earnings ratio has risen from 12.2× (Mar '23) to 16.1× (Nov '26).
The price-to-sales ratio has fallen from 0.9× (Mar '23) to 0.9× (Nov '26).
The dividend yield has risen from 4.0% (Mar '23) to 5.0% (Nov '26).

Price / earnings (P/E)

P/E

Price / sales (P/S)

P/S

Dividend yield (%)

Dividend yield %

Frequently asked questions

Is EMN growing its revenue and profit?

Over the past 5 years, Eastman Chemical Co's revenue has grown 0.7% per year, and net income declined 0.2% per year. These are computed facts, not advice.

How much debt does EMN have?

As of FY2025, Eastman Chemical Co reported $4.8B of total debt against $566M of cash.

What is EMN's profit margin?

In FY2025, gross margin was 21.1%, operating margin —, and net margin 5.4%.

What is EMN's P/E ratio?

Eastman Chemical Co's P/E (TTM) is 11.81 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the EMN stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 16.1× as of Nov '26) can differ. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.